What Equity in Private Companies Is Really Worth

What Equity in Private Companies Actually Means for Your Net Worth

Equity in private companies is ownership with a catch: you cannot price it on demand, you cannot sell it freely, and the terms buried in your cap table may mean your shares are worth far less than the headline valuation suggests. For anyone with meaningful wealth already on the table, understanding the mechanics before you accept a package or write a check is the only way to evaluate whether the illiquidity premium is worth it.

How Equity in Private Companies Is Structured

Private company equity is not monolithic. The instrument you hold determines your place in the payout queue, your tax treatment, and your practical ability to realize any value at all.

Common stock sits at the bottom of the capital structure. Employees typically receive it through options or restricted stock units. Voting rights exist on paper, but in a below-expectations exit, common stockholders frequently receive nothing after preferred investors are made whole.

Preferred stock is what institutional investors buy. It carries negotiated rights: priority in liquidation, anti-dilution protections, and sometimes board representation. Understanding public versus private equity ownership helps clarify why these structural differences matter so much in private markets, where there is no exchange to set a clearing price.

Stock options grant the right to purchase shares at a fixed strike price. The value depends entirely on the spread between that strike and the eventual exit price, minus taxes.

Restricted stock units (RSUs) deliver actual shares upon vesting. No purchase required, but ordinary income tax applies at vest, creating a cash tax obligation on an illiquid asset.

The distinction between ISOs and NSOs alone can shift your effective tax rate by 20 percentage points or more on the same underlying gain. That is not a detail to sort out after you sign.

How Is Equity in a Private Company Valued?

Without a public market, private company valuation is a negotiated estimate, not a fact. Three methods dominate.

Comparable company analysis applies revenue or EBITDA multiples from public peers or recent private transactions. The problem: private companies trade at meaningful discounts to public comparables, and the "right" multiple is genuinely contested.

Discounted cash flow models project future free cash flows and discount them at a risk-adjusted rate. For early-stage companies with no cash flow, this is largely speculative.

409A valuations are the number that actually governs your options. Under IRC Section 409A, private companies must set option strike prices at no less than fair market value as determined by a qualified independent appraisal. Granting options below that value triggers immediate income inclusion and a 20% penalty tax on top of ordinary rates. Companies typically commission 409A appraisals annually or after material funding events.

The catch: 409A valuations are deliberately conservative. They apply discounts for lack of marketability (DLOM) and lack of control (DLOC) that can reduce the appraised value to 30-50% below the preferred share price implied by the most recent funding round. Your options are struck at the 409A value, but your actual payout in an exit is measured against the preferred round valuation. That gap is where employee equity value lives, and it is not guaranteed.

Secondary market platforms including Forge Global and Nasdaq Private Market have created some price discovery for pre-IPO shares, but bid-ask spreads on secondary transactions typically run 20-40% below the most recent 409A or preferred round valuation. Many companies also retain right-of-first-refusal clauses that can block or redirect sales entirely. Liquidity before an exit is possible, but it is expensive and not guaranteed.

What Are Liquidation Preferences and How Do They Affect Common Stockholders?

This is the section that most equity compensation articles skip. It is also the one that most often determines whether employee equity is worth anything in a real exit.

A 1x non-participating liquidation preference means preferred investors recover their invested capital before common stockholders receive a dollar. In a clean outcome, this is manageable. In a below-expectations exit, it is often fatal to common equity.

A 2x participating liquidation preference is more aggressive: preferred investors receive 2x their investment, then participate pro-rata in remaining proceeds alongside common. At a company with $50M in preferred investment at 2x participating, the first $100M of any exit goes entirely to preferred holders before common sees anything.

Consider a concrete example. A company raises $40M across multiple rounds and sells for $60M. With a 1x non-participating preference stack, preferred investors collect $40M first. The remaining $20M is split among common stockholders. If there are 10 million common shares outstanding, each share receives $2.00. But if the same company has a 2x participating structure, preferred investors take $80M first. The company sold for $60M. Common stockholders receive zero.

According to the American Bar Association's Model Stock Purchase Agreement, liquidation preferences structured as participating preferred can significantly reduce or eliminate proceeds available to common stockholders in acquisition exits below certain valuation thresholds. This is not an edge case. Carta's platform data shows the median time from founding to liquidity event exceeds seven years, and the majority of venture-backed outcomes are below-expectations exits, not unicorn IPOs.

Before accepting any equity package at a company with multiple funding rounds, request the capitalization table and model the preference stack against at least three exit scenarios: the optimistic case, the expected case, and a distressed sale at 0.5x the last round valuation.

Liquidation Preference Scenarios: Common Stockholder Outcomes

ISO vs. NSO Tax Treatment: The Numbers That Matter

The tax treatment of your options is not a footnote. For a FATFIRE individual already in the top marginal bracket, the difference between ISO and NSO treatment on a $5M gain is potentially $1M or more in federal tax.

ISOs (Incentive Stock Options) defer ordinary income recognition until sale under IRC Section 422. If you hold the shares for more than two years from grant and one year from exercise, the entire gain qualifies for long-term capital gains rates. The problem: the spread at exercise is a preference item subject to the Alternative Minimum Tax under IRC Section 56.

The AMT exemption for 2024 is $85,700 for single filers and $133,300 for married filing jointly, phasing out at $609,350 and $1,218,700 respectively. High-income individuals are typically already above the phase-out threshold, meaning ISO exercises create dollar-for-dollar AMT exposure on the spread between strike price and 409A value at exercise. You owe tax on income you have not yet received in cash, on shares you cannot yet sell.

This is the ISO trap. Exercising a large grant in a single tax year without modeling AMT exposure has caused genuine financial hardship for startup employees, including well-documented cases from the dot-com era where employees paid AMT on paper gains that subsequently evaporated.

NSOs (Non-Qualified Stock Options) are simpler and harsher. The IRS requires ordinary income tax at exercise on the spread between exercise price and fair market value, regardless of whether you have sold the shares or received any cash. Your employer withholds, or you owe estimated taxes. The upside: no AMT complexity, and the tax basis in your shares steps up to the FMV at exercise, reducing future capital gains.

The practical implication: if you are evaluating a large ISO grant at a late-stage company with a 409A value significantly above your strike price, model the AMT liability before exercising. Early exercise (immediately after grant, when the spread is near zero) is often the cleanest path to starting the holding clock without triggering meaningful AMT.

How QSBS Can Eliminate Federal Tax on Private Company Gains

For qualifying positions, IRC Section 1202 is the most powerful tax elimination tool in the U.S. code. The mechanics are specific and the requirements are strict.

Under Section 1202, non-corporate taxpayers may exclude up to 100% of capital gains on Qualified Small Business Stock held for more than five years. The per-issuer exclusion cap is $10 million or 10 times the taxpayer's adjusted basis, whichever is greater. The issuing company must be a domestic C-corporation with aggregate gross assets under $50 million at the time of issuance, and the stock must be acquired at original issuance (not on a secondary market).

On a $10M gain in a qualifying position, the federal tax savings at the 23.8% long-term capital gains rate (including net investment income tax) is approximately $2.38M. That is not a rounding error.

Stacking strategies extend this further. Transferring shares to family members or trusts before a liquidity event can multiply the $10M exclusion across multiple taxpayers, each with their own cap. This requires careful planning with a tax attorney before any exit is announced, not after. Once a sale is in process, the window to restructure closes quickly.

The five-year holding requirement is absolute. Shares sold before the five-year mark receive no Section 1202 benefit. For employees who received options, the clock starts at exercise, not at grant. Early exercise matters here too.

State tax treatment varies. California, for example, does not conform to Section 1202 and taxes QSBS gains at ordinary state income tax rates. For a California resident with a $10M QSBS gain, the federal exclusion is complete, but the state tax bill at 13.3% is still $1.33M.

Vesting Schedules, Acceleration, and What to Negotiate

Standard four-year vesting with a one-year cliff means you earn 0% of your grant in year one, then 25% at the one-year anniversary, followed by monthly or quarterly vesting through year four. Leave before the cliff and you leave with nothing.

That structure is standard at early-stage companies. At later-stage companies or in executive packages, it is a negotiating point.

Single-trigger acceleration vests all or a portion of unvested equity upon a change-of-control event alone. Investors dislike it because it can create a windfall for employees who are retained post-acquisition, reducing the acquirer's incentive to pay a premium. Most venture-backed boards will not approve it.

Double-trigger acceleration is the market standard for executives. It requires both a change-of-control event AND termination without cause (or resignation for good reason) within a defined window, typically 12-18 months post-close. Without double-trigger protection, an acquirer can effectively cancel your unvested equity by keeping you employed through your vesting cliff, then terminating you after the unvested shares lapse.

Senior executives joining late-stage companies with significant unvested equity should negotiate double-trigger acceleration explicitly in their offer letters. The specific language matters: confirm that the definition of "good reason" includes material reductions in compensation, title, or responsibilities, not just outright termination.

Other terms worth negotiating: extended post-termination exercise windows (standard is 90 days after departure; some companies now offer 5-10 years), early exercise rights to start the QSBS and capital gains holding clocks, and pro-rata acceleration for partial vesting in acquisition scenarios.

Understanding governance in private equity deals is relevant here too. The board controls most of these decisions, and knowing who has influence over equity plan amendments matters before you sign.

Portfolio Concentration: How Much Illiquid Private Equity Is Too Much?

The standard retail guidance on diversification does not apply cleanly here. The question for a FATFIRE individual is not whether to hold private equity, it is how much concentration in a single illiquid position is defensible given your overall balance sheet.

Financial planning research consistently recommends limiting illiquid, concentrated single-stock positions to no more than 10-20% of total investable net worth. The National Bureau of Economic Research's long-run asset return data confirms that illiquid private equity investments require a meaningful illiquidity premium over public equities to justify the concentration risk they impose.

At $10M net worth, a $2M position in a single private company is at the upper edge of that range. At $5M net worth, a $1M position in unvested equity that you cannot sell is already a meaningful concentration risk, particularly if your human capital (your salary and career trajectory) is also tied to the same company.

The practical framework: model your private equity exposure as a percentage of liquid net worth, not total net worth. If your $5M net worth includes $3M in a primary residence and $500K in a 401(k), your liquid investable base is roughly $1.5M. A $500K private equity position is already 33% of that base.

This matters most when evaluating whether to exercise options. Exercising requires cash outlay plus potential AMT liability. If doing so would concentrate more than 20% of your liquid assets in a single illiquid position, the math needs to be compelling before you proceed. Understanding private equity distributions and returns across the asset class helps calibrate realistic expectations against that concentration cost.

How to Sell Private Company Stock Before an IPO

Pre-exit liquidity is possible but comes with real costs and constraints.

Secondary market platforms including Forge Global and Nasdaq Private Market facilitate transactions between private company shareholders and accredited investors. Typical discounts to the most recent preferred round valuation run 20-40%, and many companies retain right-of-first-refusal clauses that allow them to match any third-party offer or redirect the sale to a preferred buyer. SEC Regulation D governs these transactions, and sellers must ensure compliance with applicable exemptions, including restrictions on general solicitation and accredited investor requirements.

Company-sponsored tender offers are cleaner. The company (or its investors) organizes a structured buyback at a defined price, typically at or near the most recent 409A or a modest premium. Participation is usually limited and allocated, so you may not be able to sell your full position. These are increasingly common at late-stage companies managing employee liquidity before a delayed IPO.

Direct secondary sales to institutional buyers (family offices, dedicated secondary funds) are available for larger positions, typically $500K and above. The process is slower and requires legal review of your equity agreement, transfer restrictions, and any ROFR provisions.

The tax implications of secondary sales depend on your holding period and instrument type. Selling ISO shares before meeting the qualifying holding period triggers a disqualifying disposition, converting what would have been capital gains into ordinary income on the spread. Timing secondary sales around holding period milestones is worth modeling carefully with your tax attorney.

For context on how the structure of private equity-backed companies affects secondary sale rights, the terms vary significantly between venture-backed and PE-backed structures.

Maximizing Equity in Private Companies: A Decision Framework

The decisions that determine whether private equity compensation creates real wealth are mostly made before a liquidity event, not during one.

At grant: Determine whether shares qualify for QSBS treatment. If yes, consider early exercise to start the five-year clock. Model the cost of early exercise against the potential $10M+ tax exclusion. Confirm ISO versus NSO classification and understand the AMT implications of future exercise.

During employment: Track the preference stack as the company raises additional rounds. Each new preferred round potentially adds to the liquidation overhang sitting above your common equity. Request updated cap table information annually if you hold a meaningful position.

Before departure: Understand your post-termination exercise window. The standard 90-day window forces a binary decision: exercise (paying cash plus potential AMT) or forfeit. Negotiate an extended window before you leave, not after. Some companies now offer 5-10 year windows as a retention and goodwill measure.

Before a liquidity event: Model the full waterfall against multiple exit scenarios. If the company is exploring a sale, understand whether the proposed price clears the preference stack before common equity participates. Evaluate secondary sale options if the timeline to exit is uncertain. Understanding how private equity creates value in your specific company type informs realistic exit scenario modeling.

Tax planning: Coordinate with your tax attorney on QSBS stacking strategies, AMT credit carryforward positions, and state tax exposure well before any transaction closes.

The median time from founding to liquidity event exceeds seven years according to Carta's platform data covering thousands of private companies. That timeline is long enough to make every structural decision above worth getting right.

References

• Internal Revenue Service -- "IRC Section 1202 – Partial Exclusion for Gain from Certain Small Business Stock"
• Internal Revenue Service -- "IRC Section 422 – Incentive Stock Options"
• Internal Revenue Service -- "IRC Section 409A – Inclusion in Gross Income of Deferred Compensation Under Nonqualified Deferred Compensation Plans"
• Internal Revenue Service -- "Topic No. 427 – Stock Options"
• Internal Revenue Service -- "Instructions for Form 6251 – Alternative Minimum Tax (Individuals)" (2023)
• **U.S.

Securities and Exchange Commission** -- "Regulation D – Rules Governing the Limited Offer and Sale of Securities Without Registration Under the Securities Act of 1933"

• National Bureau of Economic Research -- "The Rate of Return on Everything, 1870–2015" (2019)
• Journal of Financial Planning -- "Concentrated Stock Positions: Risks and Strategies for High-Net-Worth Investors"
• American Bar Association -- "Model Stock Purchase Agreement and Commentary" (2010)
• Carta -- "State of Private Markets: Equity Compensation and Ownership Trends" (2023)